British Patient Capital Overview
British Patient Capital, a subsidiary of the British Business Bank, focuses on providing long-term investment to innovative UK companies. Established in 2018, it aims to support high-growth businesses by investing in venture and venture growth funds, as well as through co-investments alongside these funds. The firm emphasizes sectors where the UK has strong capabilities, such as life sciences, deep technology, and financial services. As of March 2024, British Patient Capital managed assets totaling £3.25 billion, with £2.3 billion allocated to fund and co-investments.
Is British Patient Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with British Patient Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
British Patient Capital
Investment focus
Invest in
- Baltics
- Nordics
- Western Europe
- Southern Europe
- Central Eastern Europe
- Middle East 1 / 16
Investment role
Lead and follow
Stages
Series B or later
First ticket size
£20,000,000 - £50,000,000
How to approach funds like British Patient Capital
When engaging British Patient Capital, founders should highlight how their company fits into the broader UK innovation ecosystem and demonstrates potential for significant scale. Emphasize robust traction, credible co-investors, and a clear path to market leadership, as BPC often partners with established funds and looks for signals of strong syndicate support. Articulate how your business leverages UK strengths and can deliver long-term value, aligning with BPC’s preference for patient, growth-oriented capital.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
